Glytec, a provider of intelligent glycemic management software, saw its pediatric capabilities highlighted this week through a major clinical award and continued thought-leadership outreach. The company and Advocate Health’s Beverly Knight Olson Children’s Hospital received first place at the SCCM Innovation Incubator in Chicago for work using Glytec’s Glucommander IV in pediatric diabetic ketoacidosis cases.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Peer-reviewed data span 1,372 pediatric DKA cases over more than 15 years, reportedly with zero mortality, including infants and toddlers under two years old. The results underscore how software-guided insulin and fluid dosing can standardize complex calculations and support clinical teams, particularly in community and rural hospitals with limited pediatric endocrinology resources.
Glytec emphasizes that Glucommander IV functions as a clinical decision-support tool rather than a replacement for clinician judgment. This positioning may ease regulatory and risk concerns around automation in high-acuity settings, while highlighting potential gains in safety, consistency, and scalability of inpatient glycemic care.
In parallel, Glytec continued to build its profile in hospital quality and policy circles. The company promoted a May 20 Leapfrog-hosted webinar focused on glycemic management in New York’s hospital market, framed as a fireside chat covering clinical best practices, operational workflows, and policy trends in inpatient glucose control.
By aligning its messaging with tightening CMS eCQM and Joint Commission metrics on hypoglycemia and hyperglycemia, Glytec is reinforcing its role as a partner for hospitals navigating new glycemic management standards. Overall, the week showcased both growing clinical validation in pediatric critical care and strategic visibility efforts that could support broader adoption of Glytec’s software across diverse health systems.